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Background  
Worldwide, Staphylococcus epidermidis has been recognized as leading cause of several clinically relevant infections, 
especially in neonates and immunocompromised patients. Its ability to form biofilms, particularly in the surface of 
indwelling medical devices, is the primary cause of healthcare associated infections. On the last stage of biofilm lifecycle - 
disassembly, cells are released to the surrounding environment, being able to spread the infection and cause systemic 
diseases. These cells may be defined as biofilm-released cells (Brc). It is well known that planktonic cells (PLA) are more 
susceptible to antibiotics than biofilm cells (BF). So far, little is known regarding Brc tolerance to antibiotics. 
The main goal of this work was to compare the susceptibility of Brc, PLA and BF of S. epidermidis clinical isolates, to 10 
distinct antibiotics. 
 
Method  
Brc, PLA and BF cells were obtained using a previously developed method (França et al, 2016), with different S. epidermidis 
clinical isolates. The susceptibility of all populations of S. epidermidis 9142 to peak serum concentrations (PSC) of 
Dicloxacillin, Imipenem, Teicoplanin, Vancomycin, Ciprofloxacin, Rifampicin, Erythromycin, Gentamicin, Linezolid and 
Tetracycline was assessed after 2 hours of incubation, by CFU counting. Furthermore, 11 additional isolates were studied 
upon incubation with PSC of Vancomycin, to determine whether the results are transversal to distinct isolates among the 
same species.   
 
Results & Conclusions  
Our results demonstrated that Brc present a distinct tolerance profile when exposed to some antibiotics. While studying 
isolate 9142, Brc had a distinct tolerance phenotype with 6 out of 10 antibiotics. Regarding vancomycin assays, Brc 
presented an intermediate susceptibility to vancomycin when compared with other populations with 11 out of 12 isolates. 
Thus, this study outlines the impact of Brc on pathogenesis by demonstrating that the metabolic state and cell physiology 
of Brc present a distinct antibiotic tolerance profile, and might influence antimicrobial therapies against Staphylococcal 
infections.  
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